Drug Discovery News: E. coli may hold the key to manufacturing hard-to-make drugs
Sep 16, 2021
Our founder and CEO, Sean McClain, spoke with Drug Discovery News about how Absci combines engineered E. coli with artificial intelligence to design and produce protein-based drug candidates, including antibodies.
Read the full article:
www.absci.com/ddn-ecoli